Company Profiles

driven by the PitchBook Platform

CANbridge Life Sciences

CANbridge Life Sciences
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
$40M TOTAL AMOUNT RAISED
Description

Developer of specialty healthcare products designed to treat critical medical conditions. The company's specialty healthcare products prevent and treat oral mucositis, enabling patients to access improved treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
Suite 301, 3F, Timeloit
Number 17 RongChuang Road
Beijing, Chaoyang 100102
China

+86 (0)10 8414 8018
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CANbridge Life Sciences’s full profile, request a free trial.

CANbridge Life Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 23-May-2017 $25M $40M Completed Startup
2. Early Stage VC (Series A) 02-Dec-2014 0000 0000 Completed Startup
1. Angel (individual) $5M $5M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

CANbridge Life Sciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Biossom Investment Management Other Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Lapam Capital Venture Capital Minority 000 0000 000000 0
Qiming Venture Partners Venture Capital Minority 000 0000 000000 0
TF Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

CANbridge Life Sciences Executive Team (8)

Name Title Board
Seat
Contact
Info
James Xue Ph.D Founder, Chief Executive Officer and Chairman
Paul Wagner Ph.D Chief Business Officer & Senior Vice President
Crystal Xu MD Senior Director and Head of Clinical Development
Chi-Ting Huang Ph.D Senior Director, CMC Operations
Huaizhong Hu Ph.D Vice President of Preclinical Development
You’re viewing 5 of 8 executives. Get the full list »

CANbridge Life Sciences Board Members (1)

Name Representing Role Since Contact
Info
James Xue Ph.D CANbridge Life Sciences Founder, Chief Executive Officer and Chairman 000 0000